23 March 2026
When we offered a selection of contemporary and highly relevant chemical building blocks to the scientific community to incentivize novel chemical transformations for the rapid synthesis of complex chemical structures at the end of last year, we were pleased to receive 30 high quality proposals from 20 countries. More than half of them will be supported for their studies.
Based on this success, we are excited to launch our opnMe building block initiative again in conjunction with the 2026 Frontiers in Medicinal Chemistry conference at the University of Münster, Germany. This underscores our ongoing commitment to empowering the scientific community by providing open access to high-quality, structurally diverse, and drug-relevant chemical building blocks.
By making these building blocks available for free, we want to remove a central roadblock that has often created a cycle of restricted methodology development and led to the generation of unvalidated approaches, ultimately hindering progress in synthetic chemistry.
Today, as an expert in the field, you are invited submit your proposal in response to the following question:
Presented with a selection of chemical building blocks, how would you validate chemical transformations for the rapid synthesis of complex chemical structures?
All incoming submissions will be reviewed based on scientific merit, feasibility, and potential impact. We are committed to selecting up to 20 additional proposals based on this opnMe call. Winners will be awarded with access to 500 mg of each building block of the Boehringer Ingelheim ChemKit. Our aim is to foster a vibrant community of researchers working together to push the boundaries of chemical synthesis.
Submit your ideas now! Proposals will only be accepted if received through May 11, 2026, 11:59 pm PST.
No registration required for download
Subscribe to our newsletter to stay updated as we add new calls for proposals to opnMe.com
About our call for “Molecules for Collaboration”:
On opnMe, we now offer “The Boehringer Ingelheim ChemKit”, a collection of high-quality, structurally diverse, and drug-relevant building blocks to validate chemical transformations for the rapid synthesis of complex chemical structures. Submit your proposals through May 11, 2026. Learn more…
About opnMe:
opnMe.com, the open science portal of Boehringer Ingelheim, fosters science and collaboration initiatives in areas of high unmet medical need. Our molecules are provided to the scientific community either free of charge as “Molecules to Order” or applied for via scientific research submissions as “Molecules for Collaboration”. With our “opn2EXPERTS” and “techMATCH” programs, we enlist scientific advice on key scientific topics to fuel further drug discovery and deliver novel solutions that benefit unmet patient needs. Our "opn2TALENTS" PostDoc grants at one of our research sites offer opportunities for high-level talents to propose innovative approaches for precisely defined scientific questions.